{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:05:23Z","timestamp":1784423123450,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10067-022-06469-5","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T06:08:12Z","timestamp":1670652492000},"page":"1061-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and serological factors associated with lupus pericarditis: a case\u2013control study"],"prefix":"10.1007","volume":"42","author":[{"given":"Meng-Ru","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Tzu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-5713","authenticated-orcid":false,"given":"Yao-Fan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"key":"6469_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277. https:\/\/doi.org\/10.1002\/art.1780251101","journal-title":"Arthritis Rheum"},{"key":"6469_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","volume":"14","author":"A Doria","year":"2005","unstructured":"Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14:683\u2013686. https:\/\/doi.org\/10.1191\/0961203305lu2200oa","journal-title":"Lupus"},{"key":"6469_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0961203308100659","volume":"18","author":"E Rosenbaum","year":"2009","unstructured":"Rosenbaum E, Krebs E, Cohen M, Tiliakos A, Derk CT (2009) The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Lupus 18:608\u2013612. https:\/\/doi.org\/10.1177\/0961203308100659","journal-title":"Lupus"},{"key":"6469_CR4","first-page":"149","volume":"86","author":"RL Langley","year":"1994","unstructured":"Langley RL, Treadwell EL (1994) Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc 86:149\u2013153","journal-title":"J Natl Med Assoc"},{"key":"6469_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12969-015-0005-0","volume":"13","author":"SS Maharaj","year":"2015","unstructured":"Maharaj SS, Chang SM (2015) Cardiac tamponade as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Pediatr Rheumatol Online J 13:9. https:\/\/doi.org\/10.1186\/s12969-015-0005-0","journal-title":"Pediatr Rheumatol Online J"},{"key":"6469_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.revmed.2017.01.005","volume":"38","author":"M Martin","year":"2017","unstructured":"Martin M, Guffroy A, Argemi X, Martin T (2017) Systemic lupus erythematosus and lymphopenia: clinical and pathophysiological features. Rev Med Interne 38:603\u2013613. https:\/\/doi.org\/10.1016\/j.revmed.2017.01.005","journal-title":"Rev Med Interne"},{"key":"6469_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/qjmed\/hct046","volume":"106","author":"J Merayo-Chalico","year":"2013","unstructured":"Merayo-Chalico J, G\u00f3mez-Mart\u00edn D, Pi\u00f1eir\u00faa-Men\u00e9ndez A, Santana-De Anda K, Alcocer-Varela J (2013) Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM 106:451\u2013457. https:\/\/doi.org\/10.1093\/qjmed\/hct046","journal-title":"QJM"},{"key":"6469_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08916930400022715","volume":"38","author":"P Migliorini","year":"2005","unstructured":"Migliorini P, Baldini C, Rocchi V, Bombardieri S (2005) Anti-Sm and anti-RNP antibodies. Autoimmunity 38:47\u201354. https:\/\/doi.org\/10.1080\/08916930400022715","journal-title":"Autoimmunity"},{"key":"6469_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s1568-9972(03)00082-x","volume":"3","author":"C Putterman","year":"2004","unstructured":"Putterman C (2004) New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun Rev 3:7\u201311. https:\/\/doi.org\/10.1016\/s1568-9972(03)00082-x","journal-title":"Autoimmun Rev"},{"key":"6469_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1191\/0961203305lu2107cr","volume":"14","author":"VA Nguyen","year":"2005","unstructured":"Nguyen VA, Gotwald T, Prior C, Oberrnoser G, Sepp N (2005) Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus 14:557\u2013560. https:\/\/doi.org\/10.1191\/0961203305lu2107cr","journal-title":"Lupus"},{"key":"6469_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0002-9343(92)90194-g","volume":"93","author":"H Groen","year":"1992","unstructured":"Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG (1992) Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 93:619\u2013627. https:\/\/doi.org\/10.1016\/0002-9343(92)90194-g","journal-title":"Am J Med"},{"key":"6469_CR12","first-page":"479","volume":"16","author":"DW Boulware","year":"1989","unstructured":"Boulware DW, Hedgpeth MT (1989) Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 16:479\u2013481","journal-title":"J Rheumatol"},{"key":"6469_CR13","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/1529-0131(200011)43:11","volume":"43","author":"M Ishii","year":"2000","unstructured":"Ishii M, Uda H, Yamagami T, Katada Y (2000) Possible association of \u201cshrinking lung\u201d and anti-Ro\/SSA antibody. Arthritis Rheum 43:2612\u20132613. https:\/\/doi.org\/10.1002\/1529-0131(200011)43:11","journal-title":"Arthritis Rheum"},{"key":"6469_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"6469_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1191\/0961203305lu2187oa","volume":"14","author":"BL Man","year":"2005","unstructured":"Man BL, Mok CC (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14:822\u2013826. https:\/\/doi.org\/10.1191\/0961203305lu2187oa","journal-title":"Lupus"},{"key":"6469_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0961203317716789","volume":"27","author":"IW Sohn","year":"2018","unstructured":"Sohn IW, Joo YB, Won S, Bae SC (2018) Late-onset systemic lupus erythematosus: is it \u201cmild lupus\u201d? Lupus 27:235\u2013242. https:\/\/doi.org\/10.1177\/0961203317716789","journal-title":"Lupus"},{"key":"6469_CR17","first-page":"1127","volume":"16","author":"JS Reiner","year":"1989","unstructured":"Reiner JS, Furie RA (1989) Cardiac tamponade as an initial manifestation of systemic lupus erythematosus. J Rheumatol 16:1127\u20131129","journal-title":"J Rheumatol"},{"key":"6469_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/qjmed\/hcx195","volume":"111","author":"RP Goswami","year":"2018","unstructured":"Goswami RP, Sircar G, Ghosh A, Ghosh P (2018) Cardiac tamponade in systemic lupus erythematosus. QJM 111:83\u201387. https:\/\/doi.org\/10.1093\/qjmed\/hcx195","journal-title":"QJM"},{"key":"6469_CR19","doi-asserted-by":"publisher","unstructured":"Chen YF, Hsieh MR, Chang CT, Tsai PH, Fang YF (2022) Exploring the risk factors for poor survival in lupus pericarditis patients: a retrospective cohort study. J Clin Med 11. https:\/\/doi.org\/10.3390\/jcm11185473","DOI":"10.3390\/jcm11185473"},{"key":"6469_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1756-185x.12480","volume":"20","author":"WG Li","year":"2017","unstructured":"Li WG, Ye ZZ, Yin ZH, Zhang K (2017) Clinical and immunological characteristics in 552 systemic lupus erythematosus patients in a southern province of China. Int J Rheum Dis 20:68\u201375. https:\/\/doi.org\/10.1111\/1756-185x.12480","journal-title":"Int J Rheum Dis"},{"key":"6469_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1756-185x.13761","volume":"23","author":"JH Koh","year":"2020","unstructured":"Koh JH, Park EK, Lee HN, Kim Y, Kim GT, Suh YS, Kim HO, Lee SG (2020) Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea: a multicenter retrospective cohort study. Int J Rheum Dis 23:92\u2013100. https:\/\/doi.org\/10.1111\/1756-185x.13761","journal-title":"Int J Rheum Dis"},{"key":"6469_CR22","first-page":"525","volume":"40","author":"TT Yeh","year":"2007","unstructured":"Yeh TT, Yang YH, Lin YT, Lu CS, Chiang BL (2007) Cardiopulmonary involvement in pediatric systemic lupus erythematosus: a twenty-year retrospective analysis. J Microbiol Immunol Infect 40:525\u2013531","journal-title":"J Microbiol Immunol Infect"},{"key":"6469_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1191\/0961203303lu530xx","volume":"13","author":"MH Houman","year":"2004","unstructured":"Houman MH, Smiti-Khanfir M, Ben Ghorbell I, Miled M (2004) Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients. Lupus 13:204\u2013211. https:\/\/doi.org\/10.1191\/0961203303lu530xx","journal-title":"Lupus"},{"key":"6469_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","volume":"40","author":"JJ Miner","year":"2014","unstructured":"Miner JJ, Kim AH (2014) Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 40:51\u201360. https:\/\/doi.org\/10.1016\/j.rdc.2013.10.003","journal-title":"Rheum Dis Clin North Am"},{"key":"6469_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/nejm198809293191302","volume":"319","author":"E Galve","year":"1988","unstructured":"Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817\u2013823. https:\/\/doi.org\/10.1056\/nejm198809293191302","journal-title":"N Engl J Med"},{"key":"6469_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.autrev.2018.08.010","volume":"18","author":"A Goropev\u0161ek","year":"2019","unstructured":"Goropev\u0161ek A, Holcar M, Pahor A, Av\u010din T (2019) STAT signaling as a marker of SLE disease severity and implications for clinical therapy. Autoimmun Rev 18:144\u2013154. https:\/\/doi.org\/10.1016\/j.autrev.2018.08.010","journal-title":"Autoimmun Rev"},{"key":"6469_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/qjmed\/hci155","volume":"99","author":"WL Ng","year":"2006","unstructured":"Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY (2006) Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 99:37\u201347. https:\/\/doi.org\/10.1093\/qjmed\/hci155","journal-title":"QJM"},{"key":"6469_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11910-019-1012-1","volume":"19","author":"A Shaban","year":"2019","unstructured":"Shaban A, Leira EC (2019) Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep 19:97. https:\/\/doi.org\/10.1007\/s11910-019-1012-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6469_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0961203320909952","volume":"29","author":"O Tkachenko","year":"2020","unstructured":"Tkachenko O, Lapin S, Mazing A, Emanuel V, Belolipetskaia E, Beliaeva I, Myachikova V, Maslyansky A, Schierack P, Roggenbuck D (2020) Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis. Lupus 29:490\u2013498. https:\/\/doi.org\/10.1177\/0961203320909952","journal-title":"Lupus"},{"key":"6469_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archinte.164.1.77","volume":"164","author":"G Ruiz-Irastorza","year":"2004","unstructured":"Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C (2004) High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 164:77\u201382. https:\/\/doi.org\/10.1001\/archinte.164.1.77","journal-title":"Arch Intern Med"},{"key":"6469_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1191\/096120300680199006","volume":"9","author":"M Bijl","year":"2000","unstructured":"Bijl M, Brouwer J, Kallenberg GG (2000) Cardiac abnormalities in SLE: pancarditis. Lupus 9:236\u2013240. https:\/\/doi.org\/10.1191\/096120300680199006","journal-title":"Lupus"},{"key":"6469_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/096120339400300307","volume":"3","author":"T Jouhikainen","year":"1994","unstructured":"Jouhikainen T, Pohjola-Sintonen S, Stephansson E (1994) Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus 3:167\u2013172. https:\/\/doi.org\/10.1177\/096120339400300307","journal-title":"Lupus"},{"key":"6469_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.cir.82.2.636","volume":"82","author":"RA O\u2019Rourke","year":"1990","unstructured":"O\u2019Rourke RA (1990) Antiphospholipid antibodies. A marker of lupus carditis? Circulation 82:636\u2013638. https:\/\/doi.org\/10.1161\/01.cir.82.2.636","journal-title":"Circulation"},{"key":"6469_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0002-9343(89)90337-9","volume":"86","author":"EK Chartash","year":"1989","unstructured":"Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD (1989) Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 86:407\u2013412. https:\/\/doi.org\/10.1016\/0002-9343(89)90337-9","journal-title":"Am J Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06469-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T23:31:09Z","timestamp":1679873469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06469-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["6469"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06469-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}